https://www.selleckchem.com/products/bi-4020.html
2%, respectively; = 0.00. The dominant RV genotype in the NICU was G4P[6] at 95.4%. Current RV vaccines did not affect the incidence of RV infection in newborn and preterm infants in the NICU. Most RV-positive patients in the NICU had symptoms, and the incidence of RV infection was relatively higher in hospitals and postpartum clinics with group life than home. The dominant RV genotype was G4P[6] across study groups. Current RV vaccines did not affect the incidence of RV infection in newborn and preterm infants in the NICU. Most RV-po